Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation

The development of safe and effective vaccine formulations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a hallmark in the history of vaccines. Here we report a COVID-19 subunit vaccine based on a SARS-CoV-2 Spike protein receptor binding domain (RBD) incorporated i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues-Jesus, Monica Josiane, Teixeira de Pinho Favaro, Marianna, Venceslau-Carvalho, Aléxia Adrianne, de Castro-Amarante, Maria Fernanda, da Silva Almeida, Bianca, de Oliveira Silva, Mariângela, Andreata-Santos, Robert, Gomes Barbosa, Cecilia, Brito, Samantha Carvalho Maia, Freitas-Junior, Lucio H., Boscardin, Silvia Beatriz, de Souza Ferreira, Luís Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420030/
https://www.ncbi.nlm.nih.gov/pubmed/36031045
http://dx.doi.org/10.1016/j.nano.2022.102595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420030/
https://www.ncbi.nlm.nih.gov/pubmed/36031045
http://dx.doi.org/10.1016/j.nano.2022.102595

Ejemplares similares